Treatment of Strep Throat After Amoxicillin Failure
For symptomatic patients with confirmed strep throat who fail amoxicillin treatment, switch to either a narrow-spectrum cephalosporin, clindamycin, or amoxicillin-clavulanate as these agents are reasonable alternatives with superior eradication rates. 1
Initial Assessment
Before changing antibiotics, confirm the following:
- Verify true treatment failure versus carrier state: Symptomatic patients who continue to harbor Group A Streptococcus (GAS) after completing therapy warrant retreatment, but asymptomatic patients with positive cultures are often chronic carriers who do not require additional antibiotics 1
- Assess medication adherence: Poor compliance with oral therapy is a common cause of treatment failure; if adherence is questionable, consider intramuscular benzathine penicillin G as an alternative 1
- Rule out reinfection: Exposure to infected family members or peers can cause apparent treatment failure 2, 3
Recommended Alternative Antibiotics
First-Line Alternatives (Class IIa Evidence)
Narrow-spectrum cephalosporins (e.g., cephalexin, cefadroxil):
- Provide superior bacteriologic eradication compared to penicillin 1
- Effective against beta-lactamase-producing organisms that may interfere with penicillin 2, 3
Clindamycin (300 mg four times daily for 10 days in adults):
- Highly effective for penicillin treatment failures 1
- Particularly useful for chronic carriers and recurrent infections 4
- One study showed only 3/26 patients had positive cultures after clindamycin versus 15/22 with continued penicillin 4
Amoxicillin-clavulanate:
- Overcomes beta-lactamase-producing organisms 1
- Provides broader coverage while maintaining effectiveness against GAS 3
Alternative for Penicillin-Allergic Patients
Macrolides (erythromycin, azithromycin, clarithromycin):
- Acceptable alternatives but with important caveats 1
- Macrolide resistance rates in the United States are approximately 5-8%, which can result in treatment failures 1
- Azithromycin is FDA-approved for pharyngitis/tonsillitis caused by Streptococcus pyogenes "as an alternative to first-line therapy in individuals who cannot use first-line therapy" 5
- Erythromycin has substantially higher rates of gastrointestinal side effects 1
- Critical limitation: Azithromycin should not be relied upon to prevent rheumatic fever, as data establishing efficacy in subsequent prevention are not available 5
Combination Therapy Option
Penicillin plus rifampin:
- Reasonable option for treatment failures 1
- Rifampin should never be used as monotherapy due to rapid resistance development 1
Antibiotics to Avoid
The following should NOT be used for strep throat (Class III Evidence):
- Tetracyclines: High prevalence of resistant strains 1
- Sulfonamides and trimethoprim-sulfamethoxazole: Do not eradicate GAS 1
- Older fluoroquinolones (ciprofloxacin): Limited activity against GAS 1
- Newer fluoroquinolones (levofloxacin, moxifloxacin): Unnecessarily broad spectrum and expensive 1
Follow-Up Recommendations
- Post-treatment throat cultures are indicated only for patients who remain symptomatic, have recurrent symptoms, or have a history of rheumatic fever 1
- Cultures should be performed 2-7 days after completion of therapy 1
- Do not routinely retest asymptomatic patients who have completed therapy, as many are chronic carriers 1, 6
Common Pitfalls to Avoid
- Overtreating chronic carriers: Up to 20% of school-aged children are asymptomatic GAS carriers who do not require repeated antibiotic courses 6, 7
- Assuming all positive cultures represent treatment failure: Many represent carrier state with concurrent viral infection 6, 2
- Using macrolides without considering resistance: Local resistance patterns should guide therapy, particularly if multiple macrolide courses have been given 1, 6
- Ignoring household contacts: Family members may be the source of reinfection; consider screening and treating symptomatic contacts 1, 6
Special Considerations
For patients with recurrent treatment failures despite appropriate antibiotic selection: